Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 14 clinical trials
Paclitaxel-Avelumab for Angiosarcoma

To investigate the efficacy of Avelumab when given in combination with paclitaxel as a first line treatment for the patients with inoperable angiosarcoma.

  • 14 views
  • 22 Jan, 2021
  • 1 location
Induction Paclitaxel Followed by Concurrent Paclitaxel and Radiation Therapy for Cutaneous Angiosarcoma

Angiosarcoma is a rare and aggressive form of soft tissue sarcoma. Prior work demonstrates very poor outcomes, with most patients developing metastatic disease and less than 50% surviving

  • 0 views
  • 04 Jun, 2021
  • 1 location
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

The purpose of this study is to further advance the ability to practice personalized medicine by learning which new drug agents are most effective with which types of breast cancer tumors and by learning more about which early indicators of response (tumor analysis prior to surgery via magnetic resonance imaging …

doxorubicin
neutrophil count
cancer
mammogram
erbb2
  • 79 views
  • 04 Sep, 2021
  • 30 locations
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Small cell carcinoma of the ovary, hypercalcemic type PD-L1 amplified tumors Angiosarcoma High-grade neuroendocrine carcinoma (pancreatic neuroendocrine tumor [PNET

lepidic predominant adenocarcinoma
peritoneal mesothelioma
ovarian epithelial carcinoma
systemic therapy
estimated creatinine clearance
  • 6048 views
  • 24 Sep, 2021
  • 818 locations
Propranolol in Angiosarcoma

This is a window opportunity study of propranolol in patients with angiosarcoma. The aim of this study is to prospectively evaluate the activity of propranolol in the clinical setting as

  • 0 views
  • 26 Jan, 2021
  • 1 location
Eribulin in Angiosarcoma and Epithelioid Hemangioendothelioma (EHE)

This research study is studying a drug as a possible treatment for Angiosarcoma or Epithelioid hemangioendothelioma (EHE). -The drug involved in this study is Eribulin

  • 2 views
  • 15 Feb, 2021
Testing the Addition of Nivolumab to Chemotherapy in Treatment of Soft Tissue Sarcoma

This phase II trial studies how well paclitaxel with and without nivolumab works in treating patients with soft tissue sarcoma that have not received taxane drugs, and how well nivolumab and cabozantinib work in treating taxane pretreated patients with soft tissue sarcoma. Nivolumab works through the body's immune system to …

  • 0 views
  • 23 Sep, 2021
  • 93 locations
Boron Neutron Capture Therapy Using CICS-1 and SPM-011 for Malignant Melanoma and Angiosarcoma

Among skin malignancies, patients with malignant melanoma or angiosarcoma are treated with BNCT using CICS-1 and SPM-011 (borofalan (10B)). Through this trial, safety and appropriate treatment

skin lesion
angiosarcoma
cancer
  • 0 views
  • 09 Aug, 2021
  • 1 location
A Study of Talimogene Laherparepvec (T-VEC) in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma

The purpose of this study is to determine how well the combination of therapy of talimogene laherparepvec (T-VEC) and pembrolizumab works in the treatment of patients with sarcoma.

immunomodulators
neutrophil count
cancer
systemic therapy
undifferentiated pleomorphic sarcoma
  • 60 views
  • 21 Mar, 2021
  • 1 location
Clinical and Biological Activity of an Anti-PD-L1 (Atezolizumab) in Operable Localised Soft Tissue Sarcomas Patients to be Treated With Radiotherapy

), myxofibrosarcoma, angiosarcoma versus Group 2: all translocation sarcoma except Ewing, rhabdomyosarcoma (RMS) and myxoid LPS.

  • 8 views
  • 13 May, 2021
  • 6 locations